Showing all 4 results
A small molecule NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its role in metabolic regulation. Research has focused on its ability to increase NAD+ and SAM availability, activate AMPK pathways, and promote fat cell reduction in adipocyte models. Preclinical studies show promising effects on obesity-related metabolic dysfunction and cellular energy status. For research use only.
A long-acting amylin analog studied for its role in metabolic regulation, including appetite suppression, gastric emptying delay, and body weight reduction in preclinical and clinical trials. Currently under investigation in combination with semaglutide (CagriSema) for obesity treatment. Represents an emerging class of amylin receptor agonists in metabolic research. For research use only.
A triple-receptor agonist compound studied in metabolic research for its potential effects on glucose regulation, appetite signaling, and energy homeostasis. Preclinical models have investigated its combined action on GLP-1, GLP-2, and glucagon receptor pathways. For research use only.
A mitochondria-derived peptide encoded by the mitochondrial 12S rRNA. Research has explored its regulation of metabolic homeostasis through AMPK activation, glucose metabolism improvement, and enhanced insulin sensitivity in preclinical models. Studies have examined its role in exercise physiology, energy expenditure, and age-related metabolic decline. For research use only.
End of content
End of content
Subscribe to our newsletter and get the latest trending products and offers updates.
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.
We care about your privacy
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.
Don't have an account yet? Sign up
No items in your cart. Go on, fill it up with something you love!
Start Shopping Now
